Ketim Technologies Wins Future Focused Business Achiever Award at WiT Awards 2025

Brisbane, Australia – September 5, 2025 – Ketim Technologies, a leader in biomarker-driven innovations for women’s mental health, is proud to announce that the company has won the Future Focused Business Achiever Award at the prestigious Women in Technology (WiT) Awards 2025.

This award recognises entrepreneurs and teams who are driving purposeful innovation to create a stronger future. Ketim Technologies was celebrated for its pioneering work in developing the world’s first protein blood test to predict postpartum depression, a breakthrough that has the potential to transform maternal mental health care globally.

“I am incredibly proud and grateful for this recognition,” said Dr. Clarissa Yates, Ph.D., Founder and CEO of Ketim Technologies. “This award belongs not just to me, but to our entire team, our mentors, and most importantly, the amazing mothers who contributed their samples to the Queensland Family Cohort. Without their generosity, Ketim would not exist.”

Dr. Yates expressed thanks to her mentor and Ketim Director Carrie Hillyard AM, Co-Founder Dr. Maciej Trzaskowski, Ph.D., and research partner Professor Vicki Clifton at Mater, alongside the Mater Research team. She also acknowledged the support of WiT and the award’s sponsors, including QUT, Mater Research, Powerlink Queensland, Auto & General, the Translational Research Institute Australia, and The University of Queensland.

“This recognition underscores the importance of innovation in women’s mental health and the incredible impact that collaboration across research, industry, and community can achieve,” added Dr. Yates.

For media inquiries, please contact:
Dr. Clarissa Yates
CEO, Ketim Technologies
clarissa.yates@ketim.com.au